MicroVision MOVIA lidar gains support on NVIDIA DRIVE AGX platform
Investing.com -- Shares of Becton Dickinson and Co (NYSE:BDX) climbed 3.3% following news that activist investor Starboard Value has acquired a stake in the medical technology company.
The Financial Times reported that Starboard is pushing for the sale of Becton Dickinson’s life sciences division, a move that appears to have resonated positively with investors during premarket trading.
The exact size of Starboard’s investment in Becton Dickinson has not been disclosed, as reported by the Financial Times. Both Starboard and Becton Dickinson have not commented on the matter in response to the FT’s request for statements.
This move by Starboard comes amid a broader trend of activist investors taking positions in companies to influence their strategic direction, often seeking to unlock shareholder value through changes in operations, asset sales, or other restructuring efforts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.